How can we use anthracylines in the management of newly diagnosed metastatic breast cancer patients overexpressing HER-2?
Harputluoglu
H
H
Altundag
K
K
D018943:Anthracyclines / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000556:secondary; D005260:Female; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000096:biosynthesis*
D018943:Anthracyclines; D018719:Erb-b2 Receptor Tyrosine Kinases